The automated radiosynthesis of [ 18 F]fluorocholine was carried out using a modified reactor design in 
Introduction
Choline is a quaternary ammonium salt and is an important constituent of various biological molecules [1] . It is used as a biosynthetic precursor in two processes such as in the synthesis of phospholipids and acetylcholine [2] . Choline is used for the synthesis of a particular phospholipid called phosphatidylcholine (lecithin) [3] . The metabolic pathway consists of three different steps. In the first step, the hydroxyl moiety on choline undergoes phosphorylation to choline-phosphate. This step is facilitated by adenosine triphosphate (ATP). In the penultimate step choline-phosphate reacts with CTP (choline-phosphate cytidylyltransferase) releasing pyrophosphate and forming the cytidine-5′-diphosphocholine (CDP-choline). The final step involves the conversion of CDP-choline to phosphatidylcholine [4] .
Some tumour cells are characterized by an increased uptake of choline and an over-expression of the genes encoding the choline kinase enzyme. This leads to high levels of phosphocholine available for the formation of phosphatidylcholine, whose biosynthesis is particularly increased in the tumour cells [5] .
Several studies have shown that cancer cells, especially in prostate cancer, have high concentrations of choline and decreased citrate levels [6] . The use of PET radiolabelled choline analogues for in vivo imaging, exploits these metabolic abnormalities to enabling detection of cancerous cells [7] . Choline was also found effective as a diagnostic tool in low-grade brain tumours, as precursor of the neurotransmitter acetylcholine [8] . Choline is taken up into the malignant cells and converted into phosphorylcholine, remaining trapped inside the cells. The next step is the synthesis of phosphatidylcholine which represents a key component of cell membranes [9] .
Recent reports have shown that the use of the radionuclide fluorine-18, instead of the routinely used carbon-11, could be a valuable alternative for radiolabelling choline [10] . In addition, a further benefit of this radionuclide is dependent on its longer half-life, approximately five times greater than carbon-11 (t 1/2 of carbon-11 = 20.4 min and t 1/2 of fluorine-18 = 109.8 min). Therefore fluorinated radiocompounds allow to perform a greater number of clinical examinations per imaging session, and also permitting transportation of the radiopharmaceutical to other PET imaging centres, not having a cyclotron [11] . 
Materials and Methods
(Note: For all the major products, include company name and registered office of the factory, when mentioned for the first time).
All chemicals and reagents were purchased from Sigma-Aldrich and included dibromomethane, N,Ndimethylaminoethanol, acetonitrile, ethanol, Kryptofix 2.2.2, potassium carbonate. The Sep-Pak cartridges were obtained from Waters and the reference standard fluorocholine was from ABX.
Production of 18 F
The application of the Cyclotron 18/9 IBA, equipped with a niobium target was used in the production of fluorine-18, by the irradiation of enriched water containing oxygen-18 > 97%.
Instrumentation
The radioactivity of the tracer [ ]FCH was performed with a GP50 pump (Dionex), a conductometric detector, a suppressor CRSR 300; a column (IonPac CS12A 4 mm x 250 mm, Dionex), a radioactivity detector (Bioscan Flow Counter) and a Mobil phase 20 mM MSA, working at a flow of 1 mL/min and using a current of 59 mA.
Gas-chromatography analysis
The analysis of residual solvents and DMAE, were performed using the gas chromatography system GC2010AF. The gas chromatograph (Shimadzu), was equipped with two independent chromatography lines, coupled to FID detectors. The analysis of residual solvents (acetonitrile, acetone and ethanol), was performed using the column Supelcowax 10. The analysis of DMAE, was conducted using the Rtx-5 Amine column. series to the Sep-Pak tC18. The eluents used in the purification process were 10 mL of ethanol and 10 mL of water. The final elution was performed using 3 mL of saline. The finished product was sterilized by filtration, by using a 0.22 micron filter and gave a radiochemical purity ≥ 99% area. 
Synthesis of [ 18 F]fluorocholine

Results
To optimize the production of the volatile radioactive component The radiochemical purity of [ 18 F]FCH, determined by using the second HPLC system was ≥99% area.
The final product characteristics are summarized in Table 2 . 
Discussion
In 1976, Abass Alavi was the first physician to administer the glucose analogue, 2-deoxy-2- Currently, this radiopharmaceutical is widely utilized in Nuclear Medicine with major use in positron emission tomography (PET) imaging in the application, management and detection of oncological disease states [15] . In addition, [ 18 F]FDG is also used as a standard radiotracer for PET neuro-imaging and diagnostics of cardiac and inflammatory diseases [16] . The role of [ 18 F]FDG in oncology is dependent on its affinity to accumulate inside the tumour cell where higher glucose metabolism takes place compared to normal surrounding cells [17] . However, not all tumours demonstrate significant increased metabolism of [ 18 F]FDG and this in principle is mainly true for prostate cancer, neuroendocrine tumours and hepatic malignancies [18] . For this reason, other PET radiotracers have been developed to target alternative biological processes of cancer biology [19] . One particular radiotracer of interest is choline radiolabelled with fluorine-18 or carbon-11 for the use of PET imaging [20] . control the helium flow before each synthesis run. Therefore, several tests were performed in order to reduce the residual N,N-dimethylaminoethanol (DMAE). It was necessary to condition the Sep-Pak Accell CM cartridges with aqueous hydrochloric acid (0.5 M); the residual DMAE formed was between 300 and 400 μg/mL. When the first test of conditioning was performed with water, the residual DMAE was between 40 and 50 μg/mL. Therefore, using unconditioned Sep-Pak Accell CM cartridges, a final DMAE residual less than 15 μg/mL was obtained. Moreover, using an unconditioned Sep-Pak Accell CM cartridge causes a reduction in radiochemical yield, because [ 18 F]fluorocholine was not completely retained by the SepPak Accell CM cartridge.
Conclusion
The implementation of [ 18 F]fluorocholine synthesis on a modified commercial synthesis module, i.e.
the Tracerlab has been proved to be safe and gave high, reproducible radiochemical yields. This approach to the synthesis of [ 18 F]fluorocholine will play a key role in the management and diagnosis of cancer patients.
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